VRDN
#1924
Viridian Therapeutics, Inc. - Common Stock
18.2 2 USD
0.00%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-0.44%
Variazione Mensile
-17.11%
Variazione di 6 mesi
+19.63%
Variazione Annuale
-18.84%
Chiusura Precedente
18.3 0
Open
18.0 4
Minimo
17.9 6
Massimo
18.3 3
Financials
2020
Current report, 27 Oct 2020
Viridian Therapeutics, Inc. current report, 27 October 2020
8-K
Current report, 08 Oct 2020
Viridian Therapeutics, Inc. current report, 08 October 2020
8-K
Current report, 05 Oct 2020
Viridian Therapeutics, Inc. current report, 05 October 2020
8-K
Quarterly report, Q3 FY2020
Viridian Therapeutics, Inc. quarterly report, Q3 FY2020
10-Q
Current report, 13 Sep 2020
Viridian Therapeutics, Inc. current report, 13 September 2020
8-K
Current report, 20 Aug 2020
Viridian Therapeutics, Inc. current report, 20 August 2020
8-K
Current report, 05 Aug 2020
Viridian Therapeutics, Inc. current report, 05 August 2020
8-K
Current report, 23 Jul 2020
Viridian Therapeutics, Inc. current report, 23 July 2020
8-K
Current report, 02 Jul 2020
Viridian Therapeutics, Inc. current report, 02 July 2020
8-K
Quarterly report, Q2 FY2020
Viridian Therapeutics, Inc. quarterly report, Q2 FY2020
10-Q